Study guide

15.6 Common Skin Conditions: Eczema, Contact Dermatitis, Psoriasis, Tinea, Vitiligo, Skin Lesions & Hidradenitis

WHNP-BC Women's Health Nurse Practitioner Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction: About the WHNP-BC Exam

WHNP-BC Exam Facts, Blueprint & Study Plan

2 Chapter 1: Well-Woman Care, Assessment & Gynecologic Screening

1.1 Well-Woman Health Maintenance & Routine Screening Across the Lifespan 1.2 Comprehensive Health History & Physical Examination (Female and Male) 1.3 Cervical Cancer Screening & ASCCP Risk-Based Management Guidelines 1.4 Breast Health Assessment, Diagnostic Imaging & Breast Cancer Screening

3 Chapter 2: Vulvovaginal Infections, STIs & HIV Prevention

2.1 Vulvovaginitis: Bacterial Vaginosis, Candidiasis & Trichomoniasis 2.2 Sexually Transmitted Infections: Chlamydia, Gonorrhea, Syphilis & Pelvic Inflammatory Disease 2.3 Viral STIs & Chronic Vulvar Dermatoses (HSV, HPV, Lichen Sclerosus & Lichen Planus) 2.4 HIV Prevention (PrEP & PEP), Viral Hepatitis, Mycoplasma genitalium & Ectoparasites

4 Chapter 3: Gynecologic Disorders, Pelvic Pain & Gynecologic Cancers

3.1 Abnormal Uterine Bleeding & the FIGO PALM-COEIN Classification 3.2 Uterine Leiomyomas, Adenomyosis & Endometrial and Cervical Polyps 3.3 Dysmenorrhea, Endometriosis & Chronic Pelvic Pain Management 3.4 Benign Pelvic Masses, Pelvic Organ Prolapse & Urinary Incontinence 3.5 Gynecologic Malignancies: Endometrial, Ovarian, Cervical, Vulvar & Vaginal Cancers

5 Chapter 4: Reproductive Physiology, Endocrinology & Infertility

4.1 Reproductive Anatomy, Puberty, the Menstrual Cycle & Müllerian Anomalies 4.2 Polycystic Ovary Syndrome (PCOS) & Hyperandrogenic Disorders 4.3 Amenorrhea Evaluation: Primary & Secondary Etiologies 4.4 Infertility Workup, Ovulation Induction & Assisted Reproductive Technologies

6 Chapter 5: Contraception, Family Planning & Unintended Pregnancy

5.1 Long-Acting Reversible Contraception (LARC): IUDs & Subdermal Implants 5.2 Hormonal Contraceptives: Combined & Progestin-Only Methods 5.3 Emergency Contraception, Barrier Methods & Fertility Awareness-Based Methods 5.4 CDC U.S. Medical Eligibility Criteria (US MEC) & Permanent Sterilization 5.5 Unintended Pregnancy: Options Counseling, Medication & Procedural Abortion

7 Chapter 6: Perimenopause, Menopause & Postmenopausal Health

6.1 Menopausal Transition Physiology, Vasomotor Symptoms & Clinical Staging (STRAW+10) 6.2 Menopausal Hormone Therapy (MHT): Indications, Regimens & Contraindications 6.3 Genitourinary Syndrome of Menopause (GSM) & Postmenopausal Osteoporosis

8 Chapter 7: Sexual Health, Male Reproductive Health & LGBTQ+ Care

7.1 Female Sexual Function, Sexual Dysfunction & LGBTQ+ Sexual Health 7.2 Male Sexual & Reproductive Health: STIs, Infertility, Contraception & Sexual Dysfunction

9 Chapter 8: Preconception, Fetal Development & Normal Antepartum Care

8.1 Preconception Counseling, Risk Assessment & Teratogen Exposure 8.2 Early Pregnancy Diagnosis, Gestational Dating & Initial Prenatal Evaluation 8.3 Embryonic & Fetal Development, the Placenta, Fetal Circulation & Amniotic Fluid 8.4 Routine Antepartum Surveillance, Nutritional Needs & Weight Gain Guidelines 8.5 Management of Common Discomforts & Physiologic Changes in Pregnancy

10 Chapter 9: Antepartum Complications I: Hypertension, Diabetes, Bleeding & Preterm Birth

9.1 Hypertensive Disorders of Pregnancy & Preeclampsia Management 9.2 Gestational Diabetes Mellitus: Screening, Glycemic Targets & Management 9.3 Bleeding in Pregnancy: Spontaneous Abortion, Ectopic Pregnancy & Placental Disorders 9.4 Preterm Labor, PPROM & Cervical Insufficiency

11 Chapter 10: Antepartum Complications II: Infections, Medical Disorders & Fetal Conditions

10.1 Infections in Pregnancy: CMV, Parvovirus, Varicella, Rubella, Toxoplasmosis, Listeria, GBS & HIV 10.2 Maternal Medical Disorders in Pregnancy: Pregestational Diabetes, Epilepsy, Thrombocytopenia, Obesity & Cardiac Disease 10.3 Gestational Trophoblastic Disease, Recurrent Loss, Stillbirth & Perinatal Bereavement 10.4 Multiple Gestation, Fetal Growth Disorders, Amniotic Fluid Abnormalities, Malpresentation & Postterm Pregnancy 10.5 Rh(D) Alloimmunization & Hemolytic Disease of the Fetus and Newborn

12 Chapter 11: Intrapartum Principles & Fetal Surveillance

11.1 Electronic Fetal Monitoring (EFM): Baseline, Variability, Decelerations & Categories 11.2 Labor Assessment, Stages of Labor & Labor Dystocia 11.3 Trial of Labor After Cesarean (TOLAC) & Intrapartum Emergencies

13 Chapter 12: Postpartum Management, Lactation & Puerperal Complications

12.1 Postpartum Involution, Physical Recovery & Routine Puerperal Care 12.2 Postpartum Hemorrhage: The 4 Ts, Uterotonic Pharmacotherapy & Emergency Protocols 12.3 Puerperal Infections & Postpartum Mood Disorders 12.4 Physiology of Lactation, Common Breastfeeding Challenges & Infant Feeding 12.5 Other Puerperal Complications: Hematomas, Urinary Retention, Hemorrhoids, Postpartum Hypertension & Warning Signs

14 Chapter 13: Primary Care: Cardiovascular, Thromboembolic, Respiratory & HEENT Conditions

13.1 Hypertension & Cardiovascular Disease in Women: Gender-Specific Presentations 13.2 Dyslipidemia & ASCVD Risk: The 2026 ACC/AHA Guideline 13.3 Venous Thromboembolism in Women: Risk, Diagnosis, Treatment & Prevention in Pregnancy 13.4 Respiratory Conditions in Women: Asthma Management & Respiratory Infections 13.5 HEENT & Upper Respiratory Conditions: Conjunctivitis, Rhinitis, Pharyngitis, Sinusitis, Otitis & the Common Cold

15 Chapter 14: Primary Care: Endocrine, Metabolic & Gastrointestinal Disorders

14.1 Type 2 Diabetes Mellitus & Metabolic Syndrome in Women 14.2 Obesity, Weight Management & Healthy Lifestyle Counseling 14.3 Thyroid Disorders: Hypothyroidism, Hyperthyroidism & Postpartum Thyroiditis 14.4 Gastrointestinal Conditions: GERD, Irritable Bowel Syndrome & Gallbladder Disease 14.5 Constipation, Hemorrhoids, Peptic Ulcer Disease & Other Upper and Lower GI Disorders

16 Chapter 15: Primary Care: Renal, Hematologic, Rheumatologic, Musculoskeletal & Dermatologic Health

15.1 Urinary Tract Infections, Pyelonephritis, Hematuria & Nephrolithiasis 15.2 Anemias in Women: Iron Deficiency, Microcytic & Macrocytic Anemias 15.3 Autoimmune & Rheumatologic Conditions: SLE, Antiphospholipid Syndrome, RA & Fibromyalgia 15.4 Musculoskeletal Complaints: Low Back Pain, Osteoarthritis, Sprains, Strains & Common Conditions in Women 15.5 Common Dermatologic Disorders in Women Across the Lifespan 15.6 Common Skin Conditions: Eczema, Contact Dermatitis, Psoriasis, Tinea, Vitiligo, Skin Lesions & Hidradenitis

17 Chapter 16: Neurologic, Mental Health, Behavioral & Psychosocial Care

16.1 Headache Disorders in Women: Migraine, Tension-Type, Red Flags & Hormonal Considerations 16.2 Depressive Disorders & Anxiety in Women Across the Reproductive Lifespan 16.3 Substance Use Disorders: Alcohol, Nicotine, Cannabis & Opioid Use in Women 16.4 Intimate Partner Violence (IPV), Sexual Assault & Trauma-Informed Care

18 Chapter 17: Assessment, Diagnostic Testing & Interpretation

17.1 Laboratory Diagnostics: Hematology, Coagulation, Chemistry, Hormone, Serologic & Screening Tests 17.2 Genetic Principles: Inheritance Patterns, Carrier Screening & Hereditary Cancer Risk Assessment 17.3 Gynecologic Office Diagnostic Procedures: Wet Mounts, Endometrial Biopsy & Colposcopy 17.4 Obstetric Diagnostic Imaging & Genetic Screening Modalities

19 Chapter 18: Pharmacology: Pharmacokinetics, Pharmacodynamics, Pharmacogenetics & Safe Prescribing

18.1 Clinical Pharmacokinetics Across the Female Lifespan & the FDA PLLR 18.2 Pharmacodynamics, Pharmacogenetics & Clinically Important Drug Interactions in Women's Health 18.3 Antimicrobial Stewardship & Pharmacotherapy in Pregnancy and Lactation

20 Chapter 19: Professional Role, Legal, Ethical, Quality & Health Equity Responsibilities

19.1 APRN Scope of Practice, Consensus Model & Collaborative Practice 19.2 Legal, Ethical & Informed Consent Issues in Reproductive Health Care 19.3 Evidence-Based Practice, Research Terminology, Quality Improvement & Patient Safety 19.4 Maternal Health Equity, Cultural Humility & Gender-Affirming Gynecologic Care

15.6 Common Skin Conditions: Eczema, Contact Dermatitis, Psoriasis, Tinea, Vitiligo, Skin Lesions & Hidradenitis

Key Takeaways Explain This Topic AI

Atopic dermatitis is treated with daily emollients plus topical corticosteroids for flares, with topical calcineurin inhibitors for the face and skin folds.

Allergic contact dermatitis (nickel, fragrances, poison ivy) is a type IV reaction; extensive cases need a systemic steroid taper of about 2–3 weeks, because short dose packs cause rebound.

Tinea shows an annular scaling border with central clearing and hyphae on KOH; topical azoles or terbinafine treat body infections, while scalp and nail infections need oral therapy.

Methotrexate and acitretin for psoriasis are teratogens; acitretin requires avoiding pregnancy for 3 years after stopping.

Basal cell carcinoma, the most common skin cancer, is a pearly papule with rolled borders and telangiectasias; the USPSTF finds insufficient evidence for routine clinician skin cancer screening but recommends sun-protection counseling for fair-skinned people aged 6 months to 24 years.

Last updated: October 2026

Atopic Dermatitis (Eczema)

A chronic, relapsing, intensely itchy dermatitis tied to skin barrier defects (filaggrin) and type 2 inflammation, often with asthma and allergic rhinitis. Adults typically have flexural, hand, eyelid, and neck involvement with lichenification.

Foundation: Fragrance-free emollients at least daily (after bathing), lukewarm short showers, and gentle cleansers.

Flares: Topical corticosteroids matched to site (low potency for the face, groin, and folds; medium to high potency for the trunk and extremities for limited courses).

Steroid-sparing therapy: Topical calcineurin inhibitors (tacrolimus, pimecrolimus) for the face and folds; crisaborole and topical JAK inhibitors for selected patients.

Moderate to severe disease: Phototherapy or dupilumab ; oral JAK inhibitors carry boxed warnings.

Pregnancy: Emollients and low- to mid-potency topical steroids are preferred; narrowband UVB is safe.

Contact Dermatitis

Feature Irritant Contact Dermatitis Allergic Contact Dermatitis

Mechanism Direct damage (soaps, water, solvents); no sensitization Type IV delayed hypersensitivity after sensitization

Common causes Frequent handwashing, wet work, diapers, incontinence Nickel (jewelry), fragrances, preservatives, hair dye, poison ivy/oak (urushiol) , topical antibiotics (neomycin)

Appearance Burning, dryness, fissuring at the contact site Itching, vesicles, sharp borders or linear streaks matching the exposure

Diagnosis History Patch testing for recurrent or unclear cases

Treatment: Avoid the trigger, use barrier protection and emollients, and apply topical steroids. Extensive poison ivy or facial involvement needs oral prednisone tapered over about 2–3 weeks ; a 5–6-day dose pack often causes rebound. Vulvar contact dermatitis from pads, wipes, douches, or topical anesthetics (benzocaine) is a common gynecologic presentation.

Psoriasis

An immune-mediated disease (IL-17 and IL-23 pathways) with well-demarcated, erythematous plaques with silvery scale on the extensor elbows and knees, scalp, gluteal cleft, and nails (pitting, onycholysis). It shows the Koebner phenomenon (lesions at sites of trauma). About 30% develop psoriatic arthritis , and patients have higher rates of cardiovascular disease, metabolic syndrome, and depression.

Mild disease: Topical corticosteroids, vitamin D analogs (calcipotriene), and newer nonsteroidal creams (tapinarof, roflumilast).

Moderate to severe disease: Narrowband UVB phototherapy; systemic agents including methotrexate (teratogen; stop at least 3 months before conception), acitretin (highly teratogenic; avoid pregnancy for 3 years after stopping ), apremilast, and biologics (TNF, IL-17, and IL-23 inhibitors).

Pregnancy: Psoriasis often improves; certolizumab pegol has minimal placental transfer and is preferred when a biologic is needed. Generalized pustular psoriasis of pregnancy is an emergency.

Superficial Fungal Infections (Tinea)

Diagnosis: A KOH preparation shows branching hyphae . Applying topical steroids to tinea causes "tinea incognito," a spreading, atypical rash.

Type Presentation Treatment

Tinea corporis Annular plaque with a scaling, raised border and central clearing Topical azole or terbinafine for 2–4 weeks

Tinea cruris Groin rash that spares the scrotum or vulva and labia ; candidal intertrigo involves them, with satellite lesions Topical antifungal; keep the area dry

Tinea pedis Interdigital maceration or a "moccasin" scaling pattern Topical antifungal; treat to prevent cellulitis

Tinea capitis Scaly patches with hair loss; mostly children Oral terbinafine or griseofulvin

Onychomycosis Thick, discolored, crumbling nails Confirm by culture or KOH; oral terbinafine for 12 weeks (toenails); check liver enzymes

Tinea (pityriasis) versicolor Hypo- or hyperpigmented, finely scaling macules on the trunk; KOH shows "spaghetti and meatballs" ( Malassezia ) Selenium sulfide or ketoconazole shampoo applied to the skin; pigment takes months to normalize

Oral azoles (fluconazole, itraconazole) have many drug interactions and are avoided in pregnancy.

Vitiligo

An autoimmune loss of melanocytes producing sharply demarcated depigmented macules , often around the eyes, mouth, hands, and genitals, accentuated under Wood's lamp. It is associated with autoimmune thyroid disease (check TSH), type 1 diabetes, pernicious anemia, and alopecia areata. Treatment includes topical corticosteroids, topical calcineurin inhibitors, topical ruxolitinib (FDA-approved in 2022 for nonsegmental vitiligo in patients 12 and older), and narrowband UVB, plus sun protection and attention to its psychosocial impact.

Benign, Premalignant, and Malignant Lesions

Lesion Description Management

Seborrheic keratosis Waxy, "stuck-on," brown papules Benign; remove if irritated; a sudden eruption of many lesions (Leser-Trélat sign) may signal internal cancer

  • Dermatofibroma Firm papule that dimples when pinched Benign
  • Cherry angioma Small bright red papules Benign

Actinic keratosis Rough, scaly patches on sun-exposed skin Premalignant (can become SCC); cryotherapy, topical 5-fluorouracil or imiquimod

Basal cell carcinoma Pearly papule with rolled borders and telangiectasias , may ulcerate ("rodent ulcer") Most common skin cancer ; rarely metastasizes; shave or punch biopsy, then excision or Mohs surgery

Squamous cell carcinoma Scaly, crusted, or ulcerated nodule on sun-exposed skin; higher risk with immunosuppression and HPV Can metastasize; biopsy and excision

Melanoma ABCDE changes or an "ugly duckling" lesion (see the acne, rosacea, and pregnancy dermatoses section) Excisional biopsy for Breslow depth

USPSTF: Evidence is insufficient (I statement, 2023) for routine clinician skin examination for skin cancer in asymptomatic adults, but the USPSTF recommends sun-protection counseling for fair-skinned people aged 6 months to 24 years (grade B) and selectively for older adults. Counsel on broad-spectrum SPF 30 or higher, protective clothing, and avoiding tanning beds.

Hidradenitis Suppurativa

A chronic inflammatory disease of hair follicles in the axillae, groin, inframammary folds, buttocks, and vulva , with recurrent painful nodules, abscesses, sinus tracts, and scarring. It is about three times more common in women and linked to obesity and smoking . It is often misdiagnosed as recurrent boils or Bartholin abscesses. Management includes smoking cessation and weight loss, topical clindamycin, oral tetracyclines (avoided in pregnancy), spironolactone or combined pills for hormonal flares, biologics (adalimumab, secukinumab, bimekizumab), and surgery for sinus tracts.